Home » Newsletters » BioWorld Science

BioWorld Science

May 28, 2001

View Archived Issues

Connetics makes changes to focus on dermatology business

Suppression of cold I/R injury in liver transplantation using p38 MAP kinase inhibitor

Similar reductions in cytokine production seen in monkeys treated with A-285222 or ciclosporin

Novel TNF-alpha inhibitor prevents liver failure, promotes liver regeneration following HTx

Endovasc provides Q1 2001 update

Small-molecule inhibitor of IKK complex prevents acute cardiac allograft rejection

Clinical trial demonstrates high response rate to infliximab in psoriasis

Interneuron reports product update

ATS 2001: JNK inhibitors as next-generation compounds for asthma

Xanelim shows promise in treatment of moderate to severe psoriasis

Efficacy and safety of inhaled insulin maintained over two years in diabetic patients

Company Profile: EpiGenX

GlaxoSmithKline's HIV vaccine candidate shows promise in preclinical trials

Potentially orally active, potent steroidal androgens designed at Organon

Xyrem provides overall improvement in narcolepsy patients

Potent, selective, second-generation PDE4 inhibitor with improved safety profile

Antiischemic agents from SCRAS act on mitochondria

Investigational anticancer agent phenoxodiol enters first U.S. trial

Company Profile: CoPharma

Bisphosphonic acid derivatives and use in treatment, diagnosis of bone diseases

New osteoclast vacuolar H+-ATPase inhibitors in the AstraZeneca portfolio

NK-30424 analogues useful as antitumor and antiinflammatory agents

Squalene synthase inhibitors designed at Eisai inhibit cholesterol biosynthesis

Novel diazepanes inhibit interaction of LFA-1 with ICAMs

Cytokine-inhibitory pyrimidines under evaluation at AstraZeneca

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...